Netherlands Pharmaceuticals

Pharming Group NV (PHARM)

Track

Track

Pharming Group NV experienced multiple divestments by key executives throughout 2025. The most recent insider trading activity occurred on November 26, 2025, when the Chief Medical Officer sold 90,691 shares. These transactions represent a consistent pattern of selling by leadership over the past year, with no reported acquisitions during this period.
Ticker: PHARM Exchange: AEX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pharming Group NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Relan A. Chief Medical Officer
Transaction date
Sale
Price
101.69
Quantity 59,680
Value €2,496,131
2.2
Relan A. Chief Medical Officer
Transaction date
Sale
Price
51.61
Quantity 54,693
Value €2,436,840
0.7
Outersterp, van R. Chief Compliance and Ethics Officer
Transaction date
Sale
Price
82.06
Quantity 68,744
Value €4,833,180
1.5
Toor S. Chief Commerfcial Officer
Transaction date
Sale
Price
1.06
Quantity 23,720
Value €25,143
1.5
Toor S. Chief Commercial Officer
Transaction date
Sale
Price
1.06
Quantity 876,280
Value €928,857
2.2
Sanders M. Chief Operations Officer
Transaction date
Sale
Price
1.02
Quantity 331,899
Value €338,537
1.5
Toor S. Chief Commercial Officer
Transaction date
Sale
Price
0.74
Quantity 8,778
Value €6,496
1.5
Toor S. Chief Commercial Officer
Transaction date
Sale
Price
0.74
Quantity 178,922
Value €132,402
2.2
Sanders M. Chief Operations Officer
Transaction date
Sale
Price
0.77
Quantity 199,458
Value €153,583
3.2
S. de Vries Director or Supervisory Board Member
Transaction date
Sale
Price
0.83
Quantity 48,996
Value €40,667
3.2
S. de Vries Director or Supervisory Board Member
Transaction date
Purchase
Price
0.81
Quantity 98,981
Value €80,175
3.9
S. Baert Director or Supervisory Board Member
Transaction date
Purchase
Price
0.94
Quantity 9,760
Value €9,174
3.9
L. Kruimer Director or Supervisory Board Member
Transaction date
Purchase
Price
0.94
Quantity 9,760
Value €9,174
3.8
J. van der Meijs Director or Supervisory Board Member
Transaction date
Purchase
Price
0.94
Quantity 9,760
Value €9,174
3.3
D.A. Jorn Director or Supervisory Board Member
Transaction date
Purchase
Price
0.94
Quantity 9,760
Value €9,174
3.4
B. Yanni Director or Supervisory Board Member
Transaction date
Purchase
Price
0.94
Quantity 9,760
Value €9,174
3.4
M. Pykett Director or Supervisory Board Member
Transaction date
Purchase
Price
0.94
Quantity 9,760
Value €9,174
3.4
B. Yanni Director or Supervisory Board Member
Transaction date
Purchase
Price
0.77
Quantity 9,760
Value €7,515
3.3
D.A. Jorn Director or Supervisory Board Member
Transaction date
Purchase
Price
0.77
Quantity 9,760
Value €7,515
3.8
J. van der Meijs Director or Supervisory Board Member
Transaction date
Purchase
Price
0.77
Quantity 9,760
Value €7,515
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-29 2025-11-26 S Sale
2.2
Relan A.

Chief Medical Officer
59,680
101.69
€2,496,131 		59,680 101.69 €2,496,131
2025-09-06 2025-08-29 S Sale
2.2
Relan A.

Chief Medical Officer
54,693
51.61
€2,436,840 		54,693 51.61 €2,436,840
2025-08-29 2025-08-25 S Sale
0.7
Outersterp, van R.

Chief Compliance and Ethics Officer
68,744
82.06
€4,833,180 		68,744 82.06 €4,833,180
2025-08-29 2025-08-21 S Sale
1.5
Toor S.

Chief Commerfcial Officer
23,720
1.06
€25,143 		23,720 1.06 €25,143
2025-08-29 2025-08-19 S Sale
1.5
Toor S.

Chief Commercial Officer
876,280
1.06
€928,857 		876,280 1.06 €928,857
2025-06-18 2025-06-11 S Sale
2.2
Sanders M.

Chief Operations Officer
331,899
1.02
€338,537 		331,899 1.02 €338,537
2024-08-15 2024-08-08 S Sale
1.5
Toor S.

Chief Commercial Officer
8,778
0.74
€6,496 		8,778 0.74 €6,496
2024-08-15 2024-08-07 S Sale
1.5
Toor S.

Chief Commercial Officer
178,922
0.74
€132,402 		178,922 0.74 €132,402
2024-08-09 2024-08-01 S Sale
2.2
Sanders M.

Chief Operations Officer
199,458
0.77
€153,583 		199,458 0.77 €153,583
2024-05-20 2024-05-20 S Sale
3.2
S. de Vries
Director or Supervisory Board Member
48,996
0.83
€40,667 		48,996 0.83 €40,667
2024-05-20 2024-05-20 B Purchase
3.2
S. de Vries
Director or Supervisory Board Member
98,981
0.81
€80,175 		98,981 0.81 €80,175
2022-10-27 2022-10-27 B Purchase
3.9
S. Baert
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.9
L. Kruimer
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.8
J. van der Meijs
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.3
D.A. Jorn
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.4
B. Yanni
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-10-27 2022-10-27 B Purchase
3.4
M. Pykett
Director or Supervisory Board Member
9,760
0.94
€9,174 		9,760 0.94 €9,174
2022-08-04 2022-08-04 B Purchase
3.4
B. Yanni
Director or Supervisory Board Member
9,760
0.77
€7,515 		9,760 0.77 €7,515
2022-08-04 2022-08-04 B Purchase
3.3
D.A. Jorn
Director or Supervisory Board Member
9,760
0.77
€7,515 		9,760 0.77 €7,515
2022-08-04 2022-08-04 B Purchase
3.8
J. van der Meijs
Director or Supervisory Board Member
9,760
0.77
€7,515 		9,760 0.77 €7,515
Explore more

More insider trading research around Pharming Group NV

More insider trades in Netherlands
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe